Forty years ago, 134 countries pledged to assure “Health For All” by the year 2000. They failed to deliver on that pledge. Today, at least 400 million people have no access to basic medical care, and ...
Universal Diagnostics (UDX), an in-vitro diagnostics company developing minimally-invasive, blood-based solutions for detecting cancer early, announced today promising new data for its investigational ...
Developing and implementing universal onboard diagnostics could help cut down on contractor error and improve overall system efficiency, said Glenn Hourahan ...
SEVILLE, Spain & LONDON--(BUSINESS WIRE)--Universal Diagnostics (UDX), an innovative biomedicine company focused on screening tests for the early detection of cancer, announced today the start of a ...
SEVILLE, Spain--(BUSINESS WIRE)--Universal Diagnostics (UDX), an in-vitro diagnostics company developing minimally-invasive, blood-based solutions for detecting cancer early, announced today that it ...
A study of Universal Diagnostics’ blood-based colorectal cancer test found it was more than 90 percent accurate, the company announced June 3. The blood test was found to detect colorectal cancer with ...
CAMBRDIGE, Mass. and SECAUCUS, N.J., Nov. 20, 2023 /PRNewswire/ -- Universal DX ("UDX"), a biotech company on a mission to transform cancer into a curable disease, today announced a strategic ...
Under the commercial agreement between UDX and Quest, Quest plans to perform and provide clinical laboratory services to providers and patients in the United States based on UDX's Signal-C®, an ...
Universal Diagnostics (UDX), an in-vitro diagnostics company developing minimally-invasive, blood-based solutions for detecting cancer early, announced today that it has started a prospective, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results